PRESS-RELEASE ·Filed Apr 15, 2026
Press release · Earnings
ARQT drugs
ARQT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$24.19
T+0 close · Apr 15, 2026 · via day close
Latest settled
+12.11%
T+60 · $27.12
Vs SPY
+5.07%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 16 $24.19entry
- T+1 · 7mo ago +1.41%α +0.19% · $24.53
- T+5 · 7mo ago −5.50%α −6.48% · $22.86
- T+20 · 6mo ago −10.33%α −16.15% · $21.69
- T+60 · 4mo ago +12.11%α +5.07% · $27.12
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Arcutis Biotherapeutics, Inc. announced it will report its Q1 2026 results on May 6, 2026.
Key Facts
- Arcutis Biotherapeutics, Inc. announced it will report its Q1 2026 results on May 6, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274854 |
Track record
34 reports on ARQT
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
- Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34
US Market Status
Market Closed · Opens in 9h 13m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers